New EULAR Guidelines Advise Against Stopping DMARDs in Rheumatoid Arthritis Remission
The European League Against Rheumatism (EULAR) has just updated its 2026 rheumatoid arthritis (RA) treatment guidelines, reinforcing that disease-modifying antirheumatic drugs (DMARDs) should never be stopped—even in sustained remission—due to ... Read More